SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-12-004475
Filing Date
2012-01-19
Accepted
2012-01-19 16:47:26
Documents
1
Period of Report
2012-01-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 14195
  Complete submission text file 0001209191-12-004475.txt   15641
Mailing Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615
Business Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615 (919) 862-1000
SALIX PHARMACEUTICALS LTD (Issuer) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SALIX PHARMACEUTICALS, LTD. 8540 COLONNADE CENTER DRIVE, SUITE 501 RALEIGH NC 27615
Business Address
Forbes William P (Reporting) CIK: 0001314760 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23265 | Film No.: 12535133